Acesis Holdings

Acesis Holdings Corporation was incorporated in Nevada on October 3, 2022. Acesis Holdings Corporation and its wholly-owned subsidiaries, Acesis Biomed Limited (a company incorporated in England and Wales) and Acesis Biomed US, Inc. (a Colorado corporation), are an emerging, pre-clinical stage biotechnology company focused on men's health. The company’s business model is to develop non-steroidal innovative proprietary product candidates to transform the treatment of male Low-T. The company’s pipeline of product candidates is based on discoveries by co-founder Dr. Papadopoulos, a recognized expert in the field of steroid biochemistry.